2026 Specialty Measure Set

2026 MIPS Quality Measures for Infectious Disease

The 15 MIPS quality measures designated by CMS for the Infectious Disease specialty set. These are the measures infectious disease specialists are most likely to report on, though any MIPS-eligible measure can be submitted.

15measures
7high priority
13with benchmarks
6topped out
ID ↑Measure eCQMType Status
MIPS 065Appropriate Treatment for Upper Respiratory Infection (URI)CMS154v14High PriorityTopped Out
MIPS 066Appropriate Testing for PharyngitisCMS146v14High PriorityTopped Out
MIPS 130Documentation of Current Medications in the Medical RecordCMS68v15High PriorityTopped Out
MIPS 176Tuberculosis Screening Prior to First Course of Biologic and/or Immune Response Modifier Therapy—ProcessTopped Out
MIPS 205Sexually Transmitted Infection (STI) Testing for People with HIVCMS1188v3ProcessBenchmark
MIPS 226Preventive Care and Screening: Tobacco Use: Screening and Cessation InterventionCMS138v14ProcessTopped Out
MIPS 338HIV Viral SuppressionCMS314v3High PriorityTopped Out
MIPS 340HIV Annual Retention in CareCMS1157v2High PriorityBenchmark
MIPS 387Annual Hepatitis C Virus (HCV) Screening for Patients who are Active Injection Drug Users—ProcessBenchmark
MIPS 394Immunizations for Adolescents—ProcessBenchmark
MIPS 493Adult Immunization Status—ProcessBenchmark
MIPS 503Gains in Patient Activation Measure (PAM) Scores at 12 Months—High PriorityBenchmark
MIPS 516Hepatitis C Virus (HCV): Sustained Virological Response (SVR)—High PriorityBenchmark

All Specialty Sets

Need help selecting measures?

VBCA's clinical policy team helps practices choose the right measure mix based on patient population, benchmark opportunity, and program requirements.

Get a measure-mix review →